Difference between revisions of "Theme:0bb5e4f7-9336-4ca8-92e3-c506413d1450"
From The Embassy of Good Science
Marc.VanHoof (talk | contribs) |
Marc.VanHoof (talk | contribs) |
||
| Line 2: | Line 2: | ||
|Theme Type=Good Practices | |Theme Type=Good Practices | ||
|Title=AllTrials campaign | |Title=AllTrials campaign | ||
| − | |Is About=“All trials registered, all results reported.” The AllTrials campaign is aiming towards publication of all of the results, from all clinical trials, on all treatments used | + | |Is About=“All trials registered, all results reported.” The AllTrials campaign is aiming towards publication of all of the results, from all clinical trials, on all treatments used<ref>Goldacre B. Are clinical trial data shared sufficiently today? No. BMJ.2013; 347 :f1880</ref>. Their goal is to make this a reality for present, but also for past and future clinical trials. They launched in 2013, as an initiative of Ben Goldacre, BMJ, Centre for Evidence-based Medicine, Cochrane Collaboration, James Lind Initiative, PLOS and Sense about Science. |
|Important Because=In evidence-based medicine (EBM), results from all of the studies on a particular treatment are collected and combined to make a single and robust conclusion that will impact clinical practice. To do this, researchers can only use evidence that is available to them. Research has shown that half of clinical trials end up never being published, and even more so if they have negative results about a treatment. This means that evidence informing EBM usually is distorted in favour of different treatments, which may not have the same effect in a real population, and some serious adverse events become discovered too late to prevent their impact. That is why it is important that all of the results are published, and not necessarily in journals. | |Important Because=In evidence-based medicine (EBM), results from all of the studies on a particular treatment are collected and combined to make a single and robust conclusion that will impact clinical practice. To do this, researchers can only use evidence that is available to them. Research has shown that half of clinical trials end up never being published, and even more so if they have negative results about a treatment. This means that evidence informing EBM usually is distorted in favour of different treatments, which may not have the same effect in a real population, and some serious adverse events become discovered too late to prevent their impact. That is why it is important that all of the results are published, and not necessarily in journals. | ||
|Important For=phd students | |Important For=phd students | ||
Revision as of 17:42, 12 February 2020
ThemesAllTrials campaign
What is this about?
“All trials registered, all results reported.” The AllTrials campaign is aiming towards publication of all of the results, from all clinical trials, on all treatments used[1]. Their goal is to make this a reality for present, but also for past and future clinical trials. They launched in 2013, as an initiative of Ben Goldacre, BMJ, Centre for Evidence-based Medicine, Cochrane Collaboration, James Lind Initiative, PLOS and Sense about Science.
Why is this important?
In evidence-based medicine (EBM), results from all of the studies on a particular treatment are collected and combined to make a single and robust conclusion that will impact clinical practice. To do this, researchers can only use evidence that is available to them. Research has shown that half of clinical trials end up never being published, and even more so if they have negative results about a treatment. This means that evidence informing EBM usually is distorted in favour of different treatments, which may not have the same effect in a real population, and some serious adverse events become discovered too late to prevent their impact. That is why it is important that all of the results are published, and not necessarily in journals.
For whom is this important?
The Embassy Editorial team, The Embassy editorial team, Ružica Tokalić, Iris Lechner, Natalie Evans, Philipp Hoevel, Anna Catharina Armond, Benjamin Benzon contributed to this theme. Latest contribution was Mar 25, 2021
Other information
- ↑ Goldacre B. Are clinical trial data shared sufficiently today? No. BMJ.2013; 347 :f1880
